Astellas Pharma Inc. (ALPMY)
PNK: ALPMY
· Real-Time Price · USD
9.86
-0.05 (-0.50%)
At close: May 01, 2025, 3:59 PM
Astellas Pharma Revenue
Astellas Pharma reported an annual revenue of $1,603.7B, reflecting a 5.6% growth. For the quarter ending June 30, 2024, Astellas Pharma generated $473.12B in revenue.
Revenue (ttm)
$1,603.7B
Revenue Growth
5.6%
Price / Sales Ratio
1.83
Revenue / Employee
$108.69M
Employees
14,754
Market Cap
17.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2024 | 1,603.7B | +5.60% |
| Mar 31, 2023 | 1,518.6B | +17.16% |
| Mar 31, 2022 | 1,296.2B | +3.73% |
| Mar 31, 2021 | 1,249.5B | -3.94% |
| Mar 31, 2020 | 1,300.8B | n/a |